Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WR 279,396 in Cutaneous Leishmaniasis
NCT01988909Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2013
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
A Phase 2 trial of WR 279,396 in cutaneous leishmaniasis (CL), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2013; status: completed.
02
Drugs
WR 279,396
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT01988909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01988909.